Group 1 - DocuSign (NASDAQ: DOCU) has experienced a nearly 20% correction from recent highs due to concerns regarding growth saturation [1] - The investment thesis for DocuSign now relies on the valuation correction, presenting an opportunity for potential gains [1] Group 2 - The analyst has over 20 years of experience in quantitative research, financial modeling, and risk management, focusing on equity valuation and market trends [1] - The analyst's background includes a role as Vice President at Barclays, leading teams in model validation and stress testing [1] - The research approach combines rigorous risk management with a long-term perspective on value creation, emphasizing macroeconomic trends and corporate earnings [1]